GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Net Interest Income (for Banks)

Quest PharmaTech (TSXV:QPT) Net Interest Income (for Banks)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Quest PharmaTech (TSXV:QPT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director